Results from successful ANCHOR Study in NEJM!
Results from the successful Anal Cancer/HSIL Outcomes Research (ANCHOR) study were published June 16 in the New England Journal of Medicine. This clinical trial of people living with HIV has …
New in JAMA: Expanding Efforts and Support to Respond to HIV and COVID-19
In this opinion piece featured in JAMA, Lawrence Corey, Russell Corbett-Detig, Chris Beyrer write about the exceedingly harmful effects that SARS-CoV-2 variants and HIV has had on the other. The …
New Research: Stem Cell Transplant Cures Woman Living With HIV
Use of stem cells for research has not be conducted without its share of controversy. New research using a new transplant method involving umbilical cord blood, presented at this year’s …
A highly virulent variant of HIV-1 circulating in the Netherlands
Our recent experiences with the coronavirus pandemic have demonstrated that new mutations in viral genetic sequences can have significant impacts on the virus’s transmissibility and the degrees of illness it …
New research suggests Pembrolizumab could help flush HIV from its hiding spots
How do HIV/AIDS & cancer research continue to converge? Read more about the early results from a novel study which shows that pembrolizumab, a cancer drug, can flush HIV from …
Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma
As 2021 comes to a close, we celebrate some important work published by our colleagues (Ambinder, et al) who dedicate their careers to improving diagnosis, treatment and outcomes for people …
GROUNDBREAKING RESEARCH USING ACSR SPECIMENS! Insertional activation of STAT3 and LCK by HIV-1 proviruses in T cell lymphoma
The ACSR celebrates Dr. John Mellors, et al, for their recent publication in Science and their groundbreaking research showing the important role of HIV provirus integration in the development of T-Cell Lymphoma …
A Plan for Emergency Shutdown and Reopening for a Consortium of Biobanks
The early months of the SARS-CoV-2 pandemic forced many laboratories and biobanks, including the ACSR, to develop contingency plans for biobank operations. Fear of the unknown, uncertainty and unpredictability, and …
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features
The ACSR is proud to share the latest EBV/DLBCL research from the ACSR’s own Lisa Rimsza, Alanna Maguire, and inaugural YIPA Awardee, Joo Song! EBV-positive HIV-associated diffuse large B cell …
World Cancer Day, Februrary 4, 2021
Everyday, but most especially today, World Cancer Day, the ACSR stands up to cancer. Together, all of our actions matter and the ACSR recommits to supporting our cancer warriors in …